SCHEMBL8993172

SCHEMBL8993172

CC(C)(c1ccccc1)c1ccc(-c2c[nH]nc2N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
ESR1 P03372 1/20 0.42
CYP3A4 P08684 1/20 0.42
ESR2 Q92731 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
TNK2 Q07912 2/20 0.38
MAP4K4 O95819 2/20 0.38
LTK P29376 2/20 0.38
MAPK8 P45983 2/20 0.38
CDK5 Q00535 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
DYRK1B Q9Y463 2/20 0.38
CSF1R P07333 1/20 0.38
FGFR1 P11362 1/20 0.38
PDGFRA P16234 1/20 0.38
KDR P35968 1/20 0.38
CSNK1A1 P48729 1/20 0.38
LIMK1 P53667 1/20 0.38
ACVR1 Q04771 1/20 0.38
AURKB Q96GD4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL544598 0.80 MAP4K4 (0.48) ALDH1A1SMN1; SMN2TNK2MAP4K4LTK
SCHEMBL1247672 0.76 KIF11 (0.48) MAP4K4CDK5NPC1RAB9AJAK2
SCHEMBL625013 0.74 MKNK1 (0.50) ALDH1A1ESR1CYP3A4ESR2SMN1; SMN2
SCHEMBL20263708 0.74 ALDH1A1 (0.59) ALDH1A1ESR1CYP3A4ESR2SMN1; SMN2
SCHEMBL8993116 0.73 LTA4H (0.45) CYP3A4TNK2MAP4K4LTKMAPK8
SCHEMBL7901581 0.73 MAOA (0.37) ALDH1A1CYP3A4TNK2MAP4K4LTK
SCHEMBL3724188 0.73 KDR (0.46) ALDH1A1CYP3A4SMN1; SMN2LTKDYRK1B
SCHEMBL6456244 0.72 ESR1 (0.65) ALDH1A1ESR1CYP3A4ESR2SMN1; SMN2
SCHEMBL18913698 0.70 ESR1 (0.62) ALDH1A1ESR1CYP3A4ESR2SMN1; SMN2
SCHEMBL17619924 0.70 MAPK14 (0.49) ALDH1A1TNK2MAP4K4LTKMAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1036919-C Pyrazole condensed ring derivatives, method of manufacturing the same, and androgen inhibitor OTSUKA PHARMA CO LTD (JP) 1998-01-07 CN disclosed
US-5516777-A PROSTATE CANCER THERAPY OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-05-14 US disclosed
US-5409928-A Prostate diseases, alopecia OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-04-25 US disclosed
EP-0594149-A2 Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-04-27 EP disclosed